Home › Type 2 Diabetes › Texas › Corpus Christi
Type 2 Diabetes clinical trials in Corpus Christi, TX
4 studies for Type 2 Diabetes are looking for participants at sites in and around Corpus Christi (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
RecruitingPhase 3
- Private Practice - Dr. Osvaldo A. Brusco, Corpus Christi
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
RecruitingPhase 3
- Osvaldo A Brusco MD PA, Corpus Christi
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
RecruitingPhase 3
- Osvaldo A. Brusco MD, Corpus Christi
Evaluate Use of Tropocells(R) Autologous Platelet-rich Fibrin (PRF) for Wagner Grade 1 and Grade 2, Mild to Mod Neuroischemic Plantar Diabetic Foot Ulcer Wound Care.
RecruitingPhase 2
- WoundCentrics Wound Care & Hyperbarics -Corpus Christi - Shoreline, Corpus Christi
- Woundcentrics Wound Care Center At Corpus Christi South, Corpus Christi
About Type 2 Diabetes
Type 2 Diabetes, previously referred to as Adult Onset Diabetes, is the more common type. Risk factors include obesity and family history.
More about Type 2 Diabetes on MedlinePlus
Type 2 Diabetes trials in other cities
- San Antonio, TX37 studies
- Houston, TX31 studies
- Orlando, FL24 studies
- Boston, MA20 studies
- Miami, FL19 studies
- Chicago, IL19 studies
- Dallas, TX19 studies
- Columbus, OH18 studies
- Las Vegas, NV18 studies
- Atlanta, GA17 studies
- San Diego, CA17 studies
- Los Angeles, CA16 studies
Other studies in Corpus Christi
- Obesity6 studies
- Overweight5 studies
- Burkitt Lymphoma4 studies
- Steatotic Liver Disease3 studies
- Acute Biphenotypic Leukemia3 studies
- Acute Myeloid Leukemia3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.